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A lack of consensus about the optimal treatment modalities for breast cancer in children is because of its
absolutely rare prevalence. In this article, the medical history and treatment of a secretory breast car-
cinoma in an 11-year-old girl is reported. Modiﬁed radical mastectomy (MRM) was performed on April 6,
2013. Systemic chemotherapy was performed after surgery because metastatic lymph nodes were found
in the dissected axillary tissue. Long term follow-up had to be done.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Breast cancer in children represents less than 1% of all childhood
malignancies [1] and less than 0.1% of breast tumors [2]. Levings
published the ﬁrst case of secretory (juvenile) carcinoma in a
12-year-old girl in 1917 [3].
Treatment of choice for patients with secretory breast carcinoma
is controversial. Several authors suggest conservative surgery with
sentinel lymph node biopsy [1,4,5]. Post-operative radiotherapy is
applied in adult patients who have undergone quadrantectomy but
this treatment is not advisable for children [4]. There are still no
reliable data regarding the real therapeutic value of adjuvant
chemotherapy.apy, Mashhad University of
.: þ98 (511)8525209.
mums.ac.ir (M. Joudi).
Inc. Open access under CC BY-NC-ND licen1. Case report
A symptomatic 11-year-old girl was admitted to the hospital
with a 3  3 cm lump in the subareolar region of her left breast. It
had been detected 2 years before the operation and had had a slow
growth pattern. A month prior to hospital admission history of
trauma to the breast was negative. Themass was mobile and yellow
nipple discharge was observed. No clinical axillary lymph node
involvement was detected. A heterogenous mass with deﬁned
border was the result of son logic view, which was non-speciﬁc.
Open surgical biopsy was performed. Microscopic examination
revealed neoplastic tissue arranged in micro multicystic, tubu-
loalveolar and papillary patterns. The region was abundant with
eosinophilic intracellular and extracellular secretory material
(Fig. 1). The tumor cells were round to polygonal exhibiting mod-
erate atypical the secretions in the lumen of micro cysts were PAS
positive. These ﬁndings were compatible with secretory carcinoma.
On immunohistochemistry, the tumor cells were positive
for S-100 protein but negative for estrogen and progesterone
receptor and HER2.se.
Fig. 1. Secretory breast carcinoma with micro multicystic pattern and abundant
intracellular and extracellular secretory material (H & E, 100).
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normal ranges. Modiﬁed radical mastectomy was performed on
April 6, 2013.3 out of 12 resected lymph nodes were positive for
metastatic carcinoma. Since this type of cancer is quite rare in
children, and the literature reviewwas limited to case reports, there
is no speciﬁc medical law for the treatment planning at this age.
Thus, we reviewed the case in a meeting with a radiotherapist, a
chemotherapist, a pediatricians and a surgeon, discussing the
treatment plan. Sentinel biopsy was overruled, because considering
the removal of the breast tissues, there was no tissue left for
sentinel biopsy. Chemotherapy was suggested for the patients after
the surgery by prescribing cyclophosphamide, methotrexate and
ﬂuorouracil.
2. Discussion
Breast cancer is extremely rare among children; therefore, its
clinical course is not even determined yet, resulting in disagree-
ment on treatment planning. At First the description of the secre-
tory breast carcinoma was in children, but later on it was detected
among various age groups [6e8]. It usually occurs in females but
was also reported among young males [9]. There is usually long
time span between . Long time span between the occurrence of
symptoms and treatment irrespective of age and gender is usual [5].
In our case this period was 2 years of follow-up. Our 11-year-old
patient had also positive familial history. Her aunt was treated for
breast cancer, while BRCA1e2 mutations were negative. In the
literature, a small number of patients have been reported to have
appositive family history [1,6]. Positive familial history of breast
cancer is a good indication of prognosis [6].
Despite its name, juvenile carcinoma, this distinctive pattern of
carcinoma, is not limited to children and adolescents [10,4]. This
tumor was named ‘‘secretory breast cancer’’ because tumor cells
show abundant intra- and extracellular secretion and have granulareosinophilic cytoplasm [4]. Secretory breast cancer is triple-nega-
tive (estrogen receptor-negative, progesterone receptor-negative,
and HER2-negative), lacking the beneﬁt of speciﬁc therapy that
targets these proteins; nevertheless, it has a less aggressive
behavior and amuch better prognosis than the variants observed in
adults do.
Axillary metastasis is rare and distant metastases are even rarer
[1,5,7,8]. Local treatment should involve ablation or lumpectomy
[1]. According to some authors mastectomy is the treatment of
choice because of 75% local recurrence reports after BCS [6,7].
Sentinel lymph node biopsy is chosen over axillary dissection in
order to avoid signiﬁcant complications, especially in case of a child,
who normally has a longer life span [1,10].
In general, in patients with small tumors and negative axillary
metastasis, radiotherapy is not necessary after mastectomy [1].
Because of possible late side effects (lung and chest complications),
radiotherapy must be avoided in children [10]. To decide on irra-
diation to morphological analysis of malignancy potential,
including necrosis and vessel involvement, evaluation for Ki-67
expression and p53 over expression and hormone receptor status
are necessary. Tumor size (less than 2 cm), age (less than 20 years at
the time of diagnosis), and circumscribed margins (of the tumor)
are favorable prognosis indicators [6].3. Conclusion
Because hormone receptors are mostly absent; hormonal
treatment should, therefore, be avoided [11]. Due to metastasis in
the axilla, our patient received adjuvant chemotherapy, but at the
present time there is not sufﬁcient evidence in the literature to
recommend adjuvant chemotherapy, even it has been pointed that
no chemotherapy is warranted until the appearance of new lesions.
Long term follow up should be done and a “wait-and-see” policy
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